MedTrace Logo

The Effect of Bone-Conducted Stimulation on Rotary Chair Time Constants in Patients With Vestibular Migraines

NCT06540235 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2026-05-19

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if the Otolith Labs device can improve vestibular function of subjects with vestibular migraine.

The main questions it aims to answer are:

* When the Otolith Labs device is on, are objective measures of the vestibular system better than when the device is off?
* When the Otolith Labs device is on are subjective measures of the vestibular system better than when the device is off?
* Are the objective measures related to the subjective measures?

Researchers will change the order of the device settings to ensure the changes aren't due to the order they are tested.

Participants will:

* Wear the Otolith Labs device while in a rotary chair at different settings for different tests. All of the rotary chair testing will take less than an hour.
* Answer questions about how the rotary chair testing made them feel for each test.
* Answer questions about their every-day susceptibility to motion sickness and about their vestibular migraine symptoms.

Conditions

  • Vestibular Migraine

Interventions

DEVICE

Otolith Device Active

The device will be providing different levels of stimulation hypothesized to affect the vestibular system

DEVICE

Otolith Device Inactive

The device will be providing no stimulation to measure test-retest

Sponsors & Collaborators

  • Dizzy and Vertigo Institute of Los Angeles

    collaborator UNKNOWN

  • Medical University of South Carolina

    collaborator OTHER

  • Otolith Labs

    lead INDUSTRY

Principal Investigators

  • Didier Depireux, PhD · Otolith Labs

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-27
Primary Completion
2025-08-15
Completion
2025-12-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06540235 on ClinicalTrials.gov